You are here

Prices & Quotes - UK Markets - Polarean Imaging (POLX)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 56.00p
Change Today:
-1.00p
Market Cap:
117.18m
Sector:
Health Care Equipment & Services

Polarean Imaging revenues climb as clinical trial nears completion

By Duncan Ferris

Date: Thursday 27 Jun 2019

LONDON (ShareCast) - (Sharecast News) - Polarean Imaging's shares climbed on Thursday after reporting that its annual revenues doubled to come in slightly above expectations as sales in the US soared.
The medical-imaging technology company's revenue came in at $2.4m for 2018, for an increase of 97% when compared to the year before, after revenues from its American operations rose by 192% to $2.2m.

Despite the jump in top-line growth, the AIM traded company's loss before tax deepened from $4.0m to $5.5m as administrative expenses increased by 52% to $6.2m and as Polarean continued to invest in its intellectual property portfolio, securing key new patent filings involving gas exchange and pulmonary vascular disease.

The first patient was enrolled in a phase III FDA clinical trial of Polarean's drug-device combination product for the visualisation of pulmonary function in the magnetic resonance imaging (MRI) market, with the trials now nearing completion.

Consequently, the company said it expects to receive regulatory approval in the second half of the ongoing year.

Meanwhile, Polarean said it has begun early discussions with potential strategic partners in the pharmaceutical industry and in other geographic markets that could lead to important developments in new applications and uses for its technology, expansion into new territories, potentially bringing economic benefits to the group going forward.

Polarean Imaging's shares were 12.31% higher at 21.90p at 0920 BST.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

POLX Market Data

Currency UK Pounds
Price 56.00p
Change Today -1.00p
52 Week High 106.50p
52 Week Low 42.80p
Volume 553,585
Shares Issued 209.25m
Market Cap 117.18m
Beta 0.02

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. empty sector
  4. empty sector
  5. empty sector
Income
Not Available
Growth
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector

POLX Dividends

No dividends found

Trades for 21-Jan-2022

Time Volume / Share Price
17:05 98,500 @ 56.00p
15:35 50,000 @ 56.20p
16:35 1,700 @ 56.00p
16:24 16,201 @ 54.55p
16:14 10,000 @ 54.55p

POLX Key Personnel

CEO Richard Hullihen
CFO Charles Osborne